Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
In 2021, an estimated 2.5 million people aged 18 years or older in the U.S. had opioid use disorder in the past year, yet only [...]
Xylazine appears to worsen the life-threatening effects of opioids in rats
A new study in rats suggests that xylazine, the active ingredient in a non-opioid veterinary tranquilizer not approved for human use, can worsen the life-threatening [...]
Men died of overdose at 2-3 times greater a rate than women in the U.S. in 2020-2021
Men were significantly more vulnerable than women to overdose deaths involving opioid and stimulant drugs in 2020-2021, according to a new study analyzing death records [...]
Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder
Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use [...]
NIH and FDA leaders call for more research, lower barriers to improve and implement drug- checking tools amid overdose epidemic
What: In a new Commentary in the New England Journal of Medicine, leaders at the National Institutes of Health and U.S. Food and Drug Administration [...]
Young men at highest risk of schizophrenia linked with cannabis use disorder
Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services [...]
Anti-poverty programs may help reduce disparities in brain development and mental health symptoms in children
States that provide stronger social safety nets have lower socioeconomic disparities in the brain development and mental health of children 9 to 11 years old, [...]
School prevalence of stimulant therapy for ADHD associated with higher rates of prescription stimulant misuse among teens
Researchers have identified a strong association between prevalence of prescription stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) and rates of prescription stimulant misuse (taken in a [...]
Buprenorphine initiation in the ER found safe and effective for individuals with OUD who use fentanyl
Results from a multi-site clinical trial supported by the National Institutes of Health showed that less than 1% of people with opioid use disorder whose [...]
Increased Use of Telehealth Services and Medications for Opioid Use Disorder During the COVID-19 Pandemic Associated with Reduced Risk for Fatal Overdose
The expanded availability of opioid use disorder-related telehealth services and medications during the COVID-19 pandemic was associated with a lowered likelihood of fatal drug overdose [...]